Demonstration of epitope spreading in bullous pemphigoid: Results of a prospective multicenter study

Journal of Investigative Dermatology

Volumn 131, Issue 11, 2011, Pages 2175-2177

  Hashimoto, Takashi ^a,b   Tsuruta, Daisuke ^a,b   Dainichi, Teruki ^a,b   Hamada, Takahiro ^a,b   Furumura, Minao ^a,b   Ishii, Norito ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BP180 ANTIBODY; BP230 ANTIBODY; EPITOPE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; BULLOUS PEMPHIGOID; CARBOXY TERMINAL SEQUENCE; EPITOPE MAPPING; EXTRACELLULAR SPACE; HUMAN; IMMUNOPATHOGENESIS; INTRACELLULAR SPACE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; T LYMPHOCYTE;

EID: 80054767699     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.276     Document Type: Note

References (8)

1. Chan LS, Vanderlugt CJ, Cooper KD et al. (1998) Epitope spreading: Lessons from autoimmune skin diseases. J Invest Dermatol 110:103-9 (Pubitemid 28105841)
2. Csorba K, Schmidt S, Florea F et al. (2011) Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis 6:31
3. Di Zenzo G, Thoma-Uszynski S, Fontao L et al. (2008) Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol 128:415-26
4. Di Zenzo G, Calabresi V, Olasz EB et al. (2010) Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model. J Invest Dermatol 130:1040-7
5. Di Zenzo G, Thoma-Uszynski S, Calabresi V et al. (2011) Demonstration of epitope-spreading phenomena in bullous pemphigoid: Results of a prospective multicenter study. J Invest Dermatol 131:2271-80
6. Fujihara M, Tani N, Ishii N et al. (2011) The major epitope of BP230 is limited in bullous pemphigoid cases reactive only with BP230, but covers entire domain in bullous pemphigoid cases reactive with both BP180 and BP230 [abstr 099]. J Invest Dermatol 131(Suppl 2):S17
7. Hamada T, Nagata Y, Tomita M et al. (2001) Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule. Exp Dermatol 10:256-63 (Pubitemid 32754994)
8. Yoshida M, Hamada T, Amagai M et al. (2006) Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 41:21-30 (Pubitemid 43075429)